Cross-border patient mobility within the EU has increased steadily over the past decade, yet the clinical infrastructure supporting it has not kept pace. When a patient registers with a new GP practice in a different EU country, the receiving clinician frequently has little more than what the patient can recall from memory. EU-level frameworks exist to address this, but the distance between regulatory intent and daily clinical reality remains substantial, and the consequences fall on both patients and the clinicians responsible for their care.

What the EU framework actually promises, and what it delivers

The European Health Data Space (EHDS) Regulation (EU) 2025/327, which entered into force on 26 March 2025, represents the EU's most ambitious attempt to standardise cross-border health data sharing. Under its phased timeline, full exchange of patient summaries and ePrescriptions via the MyHealth@EU infrastructure is mandated by March 2029, with medical images, laboratory results, and discharge reports following by March 2031.

The current operational layer, the eHealth Digital Service Infrastructure (eHDSI), already supports two live cross-border services: Patient Summaries and ePrescriptions. When a patient from another EU country presents at a practice connected to MyHealth@EU, the receiving clinician can, in principle, access a structured summary containing allergies, current medications, known diagnoses, and relevant clinical history, translated into the clinician's own language.

In practice, the reach of this infrastructure is limited. As of early 2025, only 15 EU Member States support patient summary and ePrescription sharing via MyHealth@EU, and 10 countries still rely on paper prescriptions. Research has identified significant interoperability barriers across EU Member States, noting that EHDS readiness varies considerably in terms of technical infrastructure, governance capacity, and data standardisation maturity.

The Patient Summary transfers a minimum dataset, not a full clinical record. It is designed for emergency and unplanned care scenarios, not for the comprehensive handover that a GP registration in a new country requires. The European Patients' Forum's analysis of the EHDS notes that many citizens still face barriers accessing their own records nationally, let alone across borders.

The specific record elements most likely to be lost in transit

Even where MyHealth@EU connectivity exists, the Patient Summary captures only a structured subset of the clinical record. The following categories are consistently absent or unreliable in cross-border transfers:

• Longitudinal consultation notes and clinical reasoning — the narrative history of how a diagnosis evolved, which differential diagnoses were considered, and what management decisions were made over time

• Mental health history and sensitive coded entries — psychiatric diagnoses, crisis presentations, and psychological assessments, which may be held in separate or restricted systems even within a single country

• Chronic disease management plans and monitoring trends — HbA1c trajectories, blood pressure monitoring over years, and disease-specific care plans that provide clinical context beyond a snapshot diagnosis code

• Vaccination records held in national registries — immunisation histories are frequently stored in standalone national databases not connected to the Patient Summary infrastructure

• Referral histories and secondary care correspondence — outpatient letters, specialist opinions, and investigation results from hospital episodes

• Surgical and procedural records — operative notes, anaesthetic histories, and implant records from hospital admissions

The Austrian Patient Summary implementation strategy illustrates the ambition required to consolidate even national records into a single structured summary, integrating data from multiple authoritative sources. The gap between that aspiration and a fully transferred longitudinal record is substantial.

Why the same EU directive produces different outcomes in different countries

The foundational Directive 2011/24/EU on cross-border healthcare establishes that healthcare providers must give patients a copy of their written or electronic medical record when seeking care abroad. What it cannot mandate is the technical capacity of receiving systems to interpret, import, or act on those records.

National medical record system architectures differ fundamentally across the EU. Some countries operate centralised, nationally standardised systems. Others rely on fragmented, vendor-specific platforms across individual practices and hospital trusts. The Council of the EU's press release on EHDS adoption acknowledges that the current level of health data digitalisation varies significantly across Member States, and that all medical record systems will need to comply with the European Electronic Health Record Exchange Format (EEHRxF) to achieve EU-level interoperability, a process that will take years.

Data residency requirements and varying national implementations of the General Data Protection Regulation (GDPR) add further asymmetry. A patient moving from Denmark, which has a mature, nationally integrated medical record system infrastructure, to Portugal faces a materially different transfer experience than one moving between two countries with shared pilot agreements. Early Finland–Estonia pilots for cross-border digital prescriptions and shared records demonstrate what bilateral infrastructure investment can achieve, but these remain exceptions rather than the norm.

The Finnish patient-facing guidance on medical records abroad is instructive: Finnish patient data can currently be transmitted electronically only to Estonia, Latvia, Norway, the Netherlands, and certain areas of Spain, as of the time of writing. Records in other countries are typically in the local language, and translation costs fall on the patient.

A Czech national survey on physician attitudes toward the Patient Summary found that awareness and use of the Patient Summary among physicians remains low, with significant barriers to adoption even in countries where the technical infrastructure exists. Even where connectivity is available, clinical uptake is not guaranteed.

How receiving clinicians fill the gaps in practice

In the absence of a complete transferred record, receiving general practitioners (GPs) typically rely on a combination of compensatory strategies:

• Patient-reported history — the most immediate source, but subject to recall bias, health literacy constraints, and language barriers

• Direct requests to the previous practice — possible under Directive 2011/24/EU but practically slow, dependent on the previous practice's responsiveness, and subject to language and format incompatibility

• Re-ordering baseline investigations — repeating blood tests, imaging, or specialist assessments that may already exist in the patient's prior record, adding cost and delay

• Re-establishing chronic disease baselines from scratch — for conditions such as type 2 diabetes, hypertension, or hypothyroidism, this may mean months of monitoring before a clinician has sufficient data to make confident management decisions

This compensatory work imposes a significant documentation burden on receiving practices. Every re-taken history, re-ordered test, and re-established baseline represents clinical time that would not be required if records transferred completely. There is also a subtler risk: clinical assumptions made in the absence of full context. A clinician who does not know a patient's prior investigation history may over- or under-investigate a new presentation, or miss the significance of a result that would be immediately interpretable against a known trend.

The medico-legal implications of an incomplete transferred record

The professional and legal exposure for receiving clinicians in this context is real and underappreciated. Prescribing decisions made without a complete allergy or drug interaction history carry inherent risk. A prior diagnosis of a bleeding disorder, an adverse drug reaction, or a contraindication to a standard treatment that exists in a foreign-language record the receiving clinician has never seen cannot protect either the patient or the clinician if something goes wrong.

The question of which party bears responsibility when a gap in transferred records contributes to a clinical error is not straightforwardly resolved by existing frameworks. Directive 2011/24/EU places the obligation to provide records on the treating (sending) provider, but receiving clinicians cannot rely on that obligation having been fulfilled. Where a patient presents without documentation, the receiving clinician's duty of care applies from the moment of first contact, including a duty to identify and document the limits of the available clinical information.

Legal analysis of the EHDS regulation published in March 2026 emphasises that healthcare organisations need to begin compliance work now rather than waiting for 2029 milestones. This analysis is primarily framed in terms of data governance, not the clinical liability exposure that arises in the interim period.

Documenting the absence of records explicitly, noting in the patient's new record that no prior documentation was available and that history was taken from patient recall alone, is both clinically and medico-legally important. It establishes the basis on which decisions were made and creates a traceable audit trail.

Sensitive and high-stakes record categories that require extra scrutiny

Certain categories of missing clinical information carry disproportionate risk, and receiving clinicians should approach these with particular care:

• Oncology history — prior malignancies, chemotherapy regimens, radiation fields, and surveillance protocols may be entirely absent. A patient who has completed treatment for a haematological malignancy may present with symptoms that are only interpretable against that background.

• Psychiatric diagnoses and psychotropic medication history — these are frequently held in separate systems, may be subject to enhanced access restrictions in the country of origin, and are among the most clinically consequential gaps when managing a patient presenting in crisis or requiring medication review.

• Controlled substance prescribing — without a clear history of prior prescribing, the receiving clinician has no basis for assessing tolerance, dependency risk, or the appropriateness of continuing a regimen.

• Safeguarding flags — child protection concerns, domestic abuse disclosures, and adult safeguarding alerts may exist in a prior record with no mechanism for cross-border transfer. These are among the most serious gaps from a patient safety perspective.

• Inherited and rare disease records — genetic diagnoses, rare condition management plans, and specialist centre correspondence are unlikely to be captured in any standardised summary and may require direct contact with specialist centres in the country of origin.

Re-documenting these categories from patient recall alone is inherently unreliable. Patients may not know their diagnoses in clinical terms, may not recall the names or doses of prior medications, or may actively choose not to disclose sensitive history in a new clinical relationship.

What clinicians should do at first presentation of a cross-border patient

A structured approach to the first consultation with a cross-border patient reduces both clinical risk and the likelihood of significant gaps persisting undetected in the new record.

At first presentation:

• Explicitly ask the patient which country they have moved from and how recently, and whether they have any documentation, including paper discharge summaries, medication lists, or test results

• Check MyHealth@EU connectivity for the patient's country of origin and, where available, access the Patient Summary with the patient's consent

• Document clearly what records were available, what was obtained from patient history, and what remains unverified

• Identify the highest-risk gaps immediately: allergy status, current medications, and any known diagnoses that would affect prescribing or investigation decisions

For record completion:

• Submit a formal request to the previous practice or national health authority for a copy of the patient's records under Directive 2011/24/EU, as this is the patient's right and the clinician can facilitate it

• For patients with complex or high-risk histories (oncology, psychiatry, rare diseases), consider direct contact with the specialist centre of origin

• Delay non-urgent clinical decisions, such as initiating new long-term medications or making referrals based on assumed prior workup, until sufficient record information is available

For documentation:

• Record the clinical basis for all decisions made under uncertainty

• Flag the record as 'incomplete prior history' to alert colleagues in subsequent consultations

• Update the record progressively as information becomes available, with clear dating of when each element was confirmed

The role of clinical documentation tools in bridging the gap

The administrative and documentation burden of onboarding a cross-border patient with limited prior records is substantial. Structured templates and clinical coding discipline can reduce the risk of important elements being omitted from the newly created record. When a clinician is reconstructing a patient's history from a combination of patient recall, partial documentation, and clinical assessment, working through a structured intake framework covering medications, allergies, diagnoses, surgical history, family history, and social context reduces the likelihood of significant gaps.

AI medical assistants (software tools that generate structured clinical notes from consultation audio) can accelerate this process, particularly where a consultation involves a complex multi-system history that would be difficult to document comprehensively in real time. Ambient voice technology (software that captures and structures the consultation as it happens) allows the clinician to focus on the patient rather than on note-taking. This is especially valuable when the consultation is longer and more information-dense than a routine appointment.

Clinical coding at the point of care, using SNOMED CT or ICD-11, also matters for the longer-term portability of the record. A free-text note describing a prior diagnosis is less useful to a future clinician, or to a future cross-border transfer, than a structured, coded entry. As the EHDS framework matures and the EEHRxF standard becomes mandatory, the quality of structured data entered into records today will determine the quality of what can be transferred tomorrow.

These tools address the documentation burden on the receiving side. They do not resolve the underlying absence of the transferred record itself. A well-structured new record built from incomplete information remains an incomplete record.

What needs to change at a systems level

The current state of cross-border record transfer reflects a structural gap that individual clinician behaviour alone cannot resolve. Several system-level changes are necessary.

Mandatory structured data standards beyond the Patient Summary. The Patient Summary was designed for emergency and unplanned care, not for GP registration. A minimum dataset for planned cross-border registration, covering longitudinal diagnoses, chronic disease management plans, and specialist correspondence, would require separate standardisation work beyond the current EEHRxF scope.

Interoperability investment across all Member States. The scoping review on EHDS interoperability barriers identifies technical infrastructure, governance capacity, and data standardisation as the primary obstacles. The 2029 compliance deadline creates a target, but the investment required to meet it is unevenly distributed across Member States. Countries with legacy systems and fragmented medical record system markets face a materially harder path than those with centralised national infrastructure.

Clearer medico-legal frameworks for cross-border record responsibility. The current framework places the obligation to provide records on the sending provider but does not adequately address the receiving clinician's position when that obligation is not fulfilled. Guidance from national medical councils and indemnity bodies on documenting and managing incomplete transferred records would reduce uncertainty for clinicians operating in this gap.

Digital literacy and clinical adoption support. The Czech physician survey and the Healthy Europe policy analysis both highlight the risk that formal data access rights remain theoretical without clinical engagement and digital literacy support needed to make them operational. Technical connectivity without clinical uptake does not improve patient safety.

Recommendations for Health Data Access Bodies within the HealthData@EU infrastructure emphasise that inconsistent digital health systems and limited cross-border sharing capacity are not primarily technical problems. They are governance and political will problems. Sustaining that will across a multi-year, multi-government implementation period is the central challenge the EHDS now faces.

Frequently asked questions

▶ What does the European Health Data Space regulation actually require for cross-border patient records?

The European Health Data Space Regulation (EU) 2025/327, which entered into force on 26 March 2025, requires full exchange of patient summaries and ePrescriptions via the MyHealth@EU infrastructure by March 2029. Medical images, laboratory results, and discharge reports must follow by March 2031. As of early 2025, only 15 EU Member States support patient summary and ePrescription sharing via MyHealth@EU, and 10 countries still rely on paper prescriptions.

▶ What clinical information is missing from a cross-border patient summary transfer?

The Patient Summary captures only a structured minimum dataset. It consistently omits longitudinal consultation notes, mental health history, chronic disease management plans, vaccination records held in national registries, referral histories, specialist correspondence, and surgical or procedural records. It was designed for emergency and unplanned care, not for the comprehensive handover a GP registration in a new country requires.

▶ Why does cross-border record transfer work differently in different EU countries?

National medical record system architectures differ fundamentally across the EU. Some countries operate centralised, nationally standardised systems. Others rely on fragmented, vendor-specific platforms. Data residency requirements and varying national implementations of the General Data Protection Regulation add further asymmetry. Finnish patient data, for example, can currently be transmitted electronically only to Estonia, Latvia, Norway, the Netherlands, and certain areas of Spain.

▶ How do GPs typically manage a new patient when no prior records are available?

Receiving GPs typically rely on patient-reported history, direct requests to the previous practice, re-ordering baseline investigations, and re-establishing chronic disease baselines from scratch. Each of these approaches adds documentation burden and clinical risk. A clinician without access to a patient's prior investigation history may over- or under-investigate a new presentation, or miss the significance of a result that would be immediately interpretable against a known trend.

▶ What are the medico-legal risks for a clinician treating a patient with an incomplete transferred record?

Prescribing decisions made without a complete allergy or drug interaction history carry inherent risk. The question of which party bears responsibility when a gap in transferred records contributes to a clinical error is not straightforwardly resolved by existing frameworks. Directive 2011/24/EU places the obligation to provide records on the sending provider, but receiving clinicians cannot rely on that obligation having been fulfilled. Documenting the absence of records explicitly, noting that history was taken from patient recall alone, is both clinically and medico-legally important.

▶ Which categories of missing clinical information carry the highest risk for cross-border patients?

Oncology history, psychiatric diagnoses and psychotropic medication history, controlled substance prescribing records, safeguarding flags, and inherited or rare disease records carry disproportionate risk. Safeguarding alerts, including child protection concerns and domestic abuse disclosures, have no mechanism for cross-border transfer. Patients may not know their diagnoses in clinical terms, may not recall prior medications, or may choose not to disclose sensitive history in a new clinical relationship.

▶ What should a GP do at the first consultation with a cross-border patient?

At first presentation, ask which country the patient has moved from and whether they have any documentation. Check MyHealth@EU connectivity for the patient's country of origin and, where available, access the Patient Summary with the patient's consent. Document clearly what records were available and what remains unverified. Identify the highest-risk gaps immediately: allergy status, current medications, and any known diagnoses that would affect prescribing or investigation decisions.

▶ Can AI medical assistants help when onboarding a cross-border patient with limited records?

AI medical assistants (software tools that generate structured clinical notes from consultation audio) can accelerate the process of reconstructing a patient's history, particularly where a consultation involves a complex multi-system history. Ambient voice technology, which captures and structures the consultation as it happens, lets the clinician focus on the patient rather than on note-taking. These tools address the documentation burden on the receiving side, but they don't resolve the underlying absence of the transferred record itself.

▶ How does clinical coding at the point of care affect future cross-border record transfers?

Clinical coding using SNOMED CT or ICD-11 matters for the longer-term portability of the record. A free-text note describing a prior diagnosis is less useful to a future clinician, or to a future cross-border transfer, than a structured, coded entry. As the European Health Data Space framework matures and the European Electronic Health Record Exchange Format standard becomes mandatory, the quality of structured data entered into records today will determine the quality of what can be transferred tomorrow.

▶ What system-level changes are needed to improve cross-border clinical record transfer?

Four changes are identified in the article. First, a minimum dataset for planned cross-border GP registration, covering longitudinal diagnoses and specialist correspondence, would require standardisation work beyond the current European Electronic Health Record Exchange Format scope. Second, interoperability investment is needed across all Member States, particularly those with legacy systems. Third, clearer medico-legal frameworks are needed for cross-border record responsibility. Fourth, clinical adoption support is required, because technical connectivity without clinical uptake doesn't improve patient safety.